Technology
Health
Biotechnology

CASI Pharmaceuticals

$3.14
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

$0.00 (0.00%) Today
-$0.02 (-0.63%) After Hours

Why Robinhood?

You can buy or sell CASI and other stocks, options, ETFs, and crypto commission-free!

About

CASI Pharmaceuticals, Inc. Common Stock, also called CASI Pharmaceuticals, is a biopharmaceutical company, which is focused on the acquisition, development and commercialization of therapeutics addressing cancer and other unmet medical needs. Read More The company develops and commercializes the oncology drugs and drug candidates in China, Taiwan, Hong Kong and Macau. Its products include ZEVALIN, EVOMELA and MARQIBO. CASI Pharmaceuticals was founded in 1991 and is headquartered in Rockville, MD.

Employees
125
Headquarters
Rockville, Maryland
Founded
1991
Market Cap
301.11M
Price-Earnings Ratio
Dividend Yield
0.00
Average Volume
365.51K
High Today
$3.19
Low Today
$3.13
Open Price
$3.16
Volume
23.74K
52 Week High
$8.89
52 Week Low
$2.73

Collections

Technology
Health
Biotechnology
Biopharmaceutical
Therapy
Cancer Prevention
Medical
Pharmaceutical

Earnings

-$0.10
-$0.07
-$0.03
$0.00
Q3 2017
Q4 2017
Q1 2018
Q2 2018
Q3 2018
Q4 2018
Q1 2019
Estimated
-$0.09 per share
Actual
-$0.09 per share

Popular Stocks

All investments involve risk and the past performance of a security, or financial product does not guarantee future results or returns. Securities offered through Robinhood Financial LLC, member FINRA/SIPC. To learn more about the information provided on this page, please see our Web Disclosures.